MARKET

LPTX

LPTX

Leap Therapeutic
NASDAQ
0.3751
+0.0401
+11.97%
After Hours: 0.3631 -0.012 -3.20% 19:25 05/12 EDT
OPEN
0.3410
PREV CLOSE
0.3350
HIGH
0.3904
LOW
0.3410
VOLUME
329.00K
TURNOVER
--
52 WEEK HIGH
4.790
52 WEEK LOW
0.2223
MARKET CAP
15.54M
P/E (TTM)
-0.2078
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LPTX last week (0505-0509)?
Weekly Report · 14h ago
Weekly Report: what happened at LPTX last week (0428-0502)?
Weekly Report · 05/05 12:05
Weekly Report: what happened at LPTX last week (0421-0425)?
Weekly Report · 04/28 12:17
Weekly Report: what happened at LPTX last week (0414-0418)?
Weekly Report · 04/21 12:16
Weekly Report: what happened at LPTX last week (0407-0411)?
Weekly Report · 04/14 12:02
Weekly Report: what happened at LPTX last week (0331-0404)?
Weekly Report · 04/07 12:02
Weekly Report: what happened at LPTX last week (0324-0328)?
Weekly Report · 03/31 12:17
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 03/27 12:05
More
About LPTX
More
Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways. The Company’s lead clinical stage drug candidate is sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is also a modulator of CKAP4/PI3K/AKT signaling. The Company is developing DKN-01 in a clinical trial in patients with colorectal cancer and has also conducted clinical trials in patients with gastric/gastroesophageal junction cancer and endometrial cancer patients. The Company also has a preclinical program to develop a proprietary monoclonal antibody known as FL-501. FL-501 is a monoclonal antibody in preclinical development that targets growth and differentiation factor 15 (GDF15), which is a cytokine that is produced at elevated levels in response to various stresses.
Recently
Symbol
Price
%Change

Webull offers Leap Therapeutics Inc stock information, including NASDAQ: LPTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LPTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LPTX stock methods without spending real money on the virtual paper trading platform.